Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
Syntopix Group plc is a drug development company focused on prescription and over-the counter products for the treatment of common inflammatory skin conditions. Our vision is to become a world-class company providing clinical solutions for important dermatological diseases. This will be achieved by creating a continuous pipeline of novel products for the topical treatment and prevention of dermatological conditions, principally acne and staphylococcal infections including MRSA. The Syntopix strategy has been designed to reduce the risks and costs associated with drug discovery and development. We concentrate on change of use and combinations of known compounds with well-documented pharmacology and toxicity profiles that are already established as safe for human ( www.syntopix.com )
Syntopix Group plc
Leeds Innovation Building 103 Clarendon Road
Leeds, LS2 9DF
United Kingdom
Tel: +44 8451 259204
Fax: +44 8451 259205